Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Silo Pharma, Inc. (SILO) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-0.83M |
|
-- |
|
-- |
|
$0.93M |
|
$-0.93M |
|
$0.10M |
|
$-0.83M |
|
$-0.92M |
|
$-0.83M |
|
$-0.83M |
|
$-0.83M |
|
$-0.92M |
|
$-0.93M |
|
$-0.86M |
|
1.10M |
|
1.10M |
|
$-0.76 |
|
$-0.76 |
|
| Balance Sheet Financials | |
$5.71M |
|
-- |
|
$0.24M |
|
$5.95M |
|
$1.07M |
|
-- |
|
-- |
|
$1.07M |
|
$4.89M |
|
$4.67M |
|
$4.89M |
|
1.13M |
|
| Cash Flow Statement Financials | |
$-1.60M |
|
$0.16M |
|
$-0.03M |
|
$4.75M |
|
$3.28M |
|
$-1.47M |
|
$0.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.36 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.04% |
|
-17.82% |
|
-13.99% |
|
-17.04% |
|
$4.33 |
|
$-1.42 |
|
$-1.46 |
|